分享至
简介
基本信息
技术文档
上下游信息
相关文章
评价
咨询
售后
产品简介
Information NVP-CGM097 NVP-CGM097 is a highly potent and selective MDM2 inhibitor with Ki value of 1.3 nM for hMDM2 in TR-FRET assay. It binds to the p53 binding-site of the Mdm2 protein, disrupting the interaction between both proteins, leading to an activation of the p53 pathway. Targets hMDM2 (Cell-free assay) 1.7 nM In vitro NVP-CGM097 binding to MDM2 is species dependent. It was shown to be selective for the p53:MDM2 interaction compared to the p53:MDM4 interaction (1176-fold selectivity) and the Ras:Raf interaction (3000-fold selectivity). In addition, NVP-CGM097 showed no significant activity against Bcl-2:Bak, Bcl-2:Bad, Mcl-1:Bak, Mcl-1:NOXA, XIAP:BIR3, and c-IAP:BIR3 protein-protein interactions. NVP-CGM097 was able to significantly redistribute wild-type p53 into the cell nucleus with an IC50 of 0.224 μM, demonstrating its ability to inhibit the p53:MDM2 interaction in living cells. NVP-CGM097 treatment leads to p53 nuclear translocation that results in cell growth inhibition in a p53-dependent manner. In vivo After iv administration, the total blood clearance (CL) of NVP-CGM097 was 5 mL/min/kg for mouse, 7 mL/min/kg for rat, 3 mL/min/kg for dog, and 4 mL/min/kg for monkey. On the basis of the respective hepatic blood flows, NVP-CGM097 showed a consistent low total blood CL in all species (5-10% of hepatic blood flow). The apparent terminal half-life (t1/2) was long in rodents and monkey (6-12 h) but was comparatively longer in dogs (20 h). After oral dosing, the compound was well absorbed with Tmax occurring between 1 and 4.5 h in all species tested. The oral bioavailability (%F) was high in mouse, rat, and dog and moderate in monkey. NVP-CGM097 was able to inhibit the interaction between p53 and MDM2 and reactivate the p53 pathway in vivo in a MDM2-amplified SJSA-1 human tumor model. p21 mRNA levels were found to increase concomitantly with levels of compound 1 in tumor-bearing rats dosed at 30 mg/kg. Daily treatment with NVP-CGM097 dose dependently and significantly inhibited SJSA-1 tumor growth in rats. Cell Research(from reference) Cell lines:Bon1 cells, NCI-H727 cells, Got1 cells Concentrations:0.1 nM-2500 nM Incubation Time:48 hrs, 96 hrs, 144 hrs or 216 hrs
中文名称
NVP-CGM097
英文名称
NVP-CGM097
中文别名
-
英文别名
AKOS030526402 | BP-10652 | NSC783015 | NSC-783015 | SCHEMBL2391196 | CCG-270337 | Uridine pyrophosphate a-delta-galactopyranosyl ester | BDBM162123 | CGM 097 [WHO-DD] | MFCD28144684 | (1S)-1-(4-chlorophenyl)-6-methoxy-2-[4-(methyl{[trans-4-(4-methyl-3-oxo
CAS号
1313363-54-0
分子式
C38H47ClN4O4
分子量
659.26 g/mol
精确质量
10mM in DMSO
PSA
65.600 Ų
Logp
6.455
技术文档
「暂无技术文档」
上下游信息
「暂无上下游信息」
相关文章
「暂无相关文章」
用户评价
加载中...
商品咨询

温馨提示:

因厂家可能临时调整产品规格、价格、库存、参数等信息且不另行通知,同时每位用户的咨询时间、采购需求存在差异,平台回复内容仅在一定时期内具有参考价值。由此给您带来的不便,敬请谅解,感谢您的理解与支持!最新详细信息请咨询在线客服,一切以客服实时回复为准!

售后服务

收到货品请及时核对数量、外观及产品信息,如遇破损、错发、质量异常等问题,欢迎随时联系我们。

服务热线:400-6226-992 ,我们将第一时间为您处理,感谢您的支持与信任!

NVP-CGM097 100mg

Mdm2抑制剂

品牌:阿拉丁
货号:N413861-100mg
级别: ≥98%
货期:30天
已售 754 件
19775
.88
23731
.06
配送至: 请选择地址
运费:0 元
规格:

100mg

数量

精选好物